Most people think of paralysis in terms of not being able to move or walk. But there is another side to being paralyzed , the lack of sensation. The inability to feel pain leaves the person susceptible to burns from inadvertent contact with hot surfaces. Researchers at the Broad Center for Regenerative Medicine and Stem Cell Research at UCLA have developed a new protocol which could serve as the first step toward stem cell-based therapies to restore sensation in paralyzed people who have lost feeling in parts of their body.
Read More
Tags:
Stem cell research,
LAVS,
UCLA,
laboratory equipment suppliers,
Lab Product Sales,
research news,
UC Los Angeles,
BioResearch Product Faire,
UCLA research funding,
general lab supply,
2017 research funding,
nih research funding
“Despite dramatic improvements in the ability to treat and prevent HIV, the HIV rate among youth in America has doubled in the last 10 years,” Mary Jane Rotheram-Borus, director of the Global Center for Children and Families at UCLA stated in a recent article for the UCLA Newsroom. By 2020 the incidence of the disease among youths is expected to increase by 39%. Dr. Rotheram-Boras believes that if acutely infected youths were identified and treated during the period when their infectivity to others is 5-10 fold, then the medical community could reverse this trend and improve the long-term health of youths.
(Image of UCLA courtesy of Wikimedia)
Read More
Tags:
LAVS,
UCLA,
Laboratory Equipment Supplier,
Lab Product Sales,
NIH grants,
UC Los Angeles,
BioResearch Product Faire,
UCLA research funding,
Laboratory product sales,
general lab supply,
2017 research funding
In 1998 Mattel’s gift of $25 million made the construction of the UCLA Mattel Children’s Hospital possible. In March 2017 Mattel made a $50M commitment to the UCLA Foundation to expand the hospital’s pediatric services. Over the last 20 years, Mattel has provided more than $80 million to UCLA’s health care system to support its Children’s Hospital.
(Image of Dr. John Mazziotta, vice chancellor of UCLA Health Sciences and Richard Dickson, president of Mattel, announcing the $50 million gift courtesy of UCLA Newsroom)
Read More
Tags:
LAVS,
UCLA,
Lab Product Sales,
UC Los Angeles,
BioResearch Product Faire,
2017 research funding,
UCLA hospital
The National Institutes of Health has awarded the University of California, Los Angeles a $7.2 million life science grant to study genetic diseases and develop ways to diagnose rare genetic disorders. UCLA is the only university on the West Coast and one of only three in the United States with a laboratory that can carry out genomic sequence directly usable for patient care, making it the ideal university to receive this life science grant.
Read More
Tags:
2014,
CA,
new research funding,
Southwest,
Los Angeles,
LAVS,
UCLA,
Biotechnology Vendor Showcase,
life science grant,
UC Los Angeles
Remember life as a starving student? How about grad school? How about your post doctoral fellowship?
Tags:
2014,
University of Michigan Ann Arbor,
BioResearch Product Faire Event,
Life Science Event,
Biotechnology Vendor Showcase,
UC Riverside,
UC San Francisco,
UC Davis - Medical Center,
UC Berkeley,
UC Irvine,
post doc,
salary,
UC Los Angeles
Are you struggling to find answers to your research challenges? Tired of using outdated technologies, techniques, and equipment? We may able to help. Biotechnology Calendar, Inc. would like to invite you to the 33rd semiannual Biotechnology Vendor Showcase™ Event on Thursday, April 3, 2014.
Tags:
2014,
CA,
California,
Los Angeles,
LAVS,
UCLA,
Biotechnology Vendor Showcase,
UC Los Angeles
UCLA Market Highlights
With annual research expenditures of over $1 billion and one of the largest medical centers in the nation, Los Angeles provides one of the most active, research marketplace opportunities in the nation.
17 Fast Facts about UCLA Marketplace:
Tags:
2014,
CA,
Los Angeles,
LAVS,
Biotechnology Vendor Showcase,
UC Los Angeles
Are you a lab supplier who is looking to increase your presence or expand your influence at the top California Universities? Take advantage of these upcoming life science trade shows that will provide you with an effective way to network with leading California researchers:
Read More
Tags:
2014,
CA,
2013,
University of Southern California,
Southwest,
USC,
Los Angeles,
LAVS,
San Diego,
SDVS,
BioResearch Product Faire Event,
UC San Diego,
Biotechnology Vendor Showcase,
Riverside,
UC Riverside,
Irvine,
UCI,
UC Irvine,
UCR,
UC Los Angeles
The NIH has just announced $5.3M in two new awards through the Autism Centers of Excellence (ACE) program to support autism research studies led by two University of California investigative teams, at UCLA and the UC Davis Medical Center MIND Institute. ACE funding is earmarked for large, multi-disciplinary studies into the origins of autism spectrum neurological disorders and avenues for their treatment. In the case of the two latest awardees, one is a clinical behavioral study and one is a study of genetic variants. The $5.3M is initial one-year funding, with extensions of up to five years. The ACE program includes both centers and networks. Centers are made up of multiple investigators at one site working together on a specific research problem; networks include investigative teams from different sites engaged in a focused study. Both UCLA and UC Davis are ACE centers and will lead the current research projects, though in collaboration with colleagues at other research institutions, namely Harvard, UW, Vanderbilt, Emory, Johns Hopkins, and Yale. As with all ACE research, data and findings are collected centrally by the NIH to maximize their availability to the larger research community.
Read More
Tags:
2014,
CA,
2013,
Southwest,
Los Angeles,
Autism,
LAVS,
UCDMC,
BioResearch Product Faire Event,
Funding,
UCLA,
Genetics,
Research,
Sacramento,
Davis,
NIH funding,
UC Los Angeles,
UC Davis,
Biotechnology Vendor Showcase Event
The California Institute for Regenerative Medicine (CIRM) is a major funding agency for stem cell research in the Golden State. Since voters approved the establishment of the agency in 2004, the CIRM has spent billions on research and facilities with the aim of making California the stem cell capital of the US. Now, in a move to advance that research mission even further, the agency has announced awards of $32M to investigators and stem cell companies to create a biobank of diseased cell lines for the use of researchers around the world. Called the Human Induced Pluripotent Stem Cell (hiPSC) Initiative Awards, the project will generate and ensure the availability of high quality disease-specific hiPSC resources for disease modeling, target discovery and drug discovery and development for prevalent, genetically complex diseases.
Read More
Tags:
2014,
CA,
2013,
Stem cell research,
Southwest,
California,
Los Angeles,
Biobank,
biobanking,
LAVS,
San Diego,
SDVS,
San Francisco,
SFVS,
UC San Diego,
Biotechnology Vendor Showcase,
UC San Francisco,
CIRM,
Parnassus Campus,
tradeshow,
Mission Bay Campus,
Parnassus,
Mission Bay,
BVS,
UC Los Angeles
